Until recently, the treatment for cerebral palsy consisted of orthopaedic surgery, therapy and bracing. For may years, these traditional treatments were the only options available fo rpatients with cerebral palsy. The goal was to correct the contractures or bony deformity caused by spasticity and to improve function. Newer treatments are now available to decrease the spasticity associated with cerebral palsy. Each of these interventions – botulinum toxin A (commonly referred to by its trade name Botox®), an intrathecal baclofen pump and selective posterior rhizotomy has unique properties, advantages and disadvantages. The goal of these treatments is to provide an increased ease of movement by decreasing unwanted muscle activity. They are often done in conjunction with traditional treatments such as therapy, equipment, and sometimes orthopaedic surgery to maximize functional independence.